Review highlights EP4 receptor as target for inflammatory diseases
A review published in Genes & Diseases highlights the prostaglandin E2 receptor subtype 4 (EP4) as an important regulator of inflammation and a promising therapeutic target for a wide range of inflammatory and inflammation-related diseases.
Read original article on The Medical News →Related news
-
Stem cell–like tumor state may help identify high-risk small-cell lung cancer
United Kingdom
-
Novel study explores how different types of genetic risk impact the manifestation of alcohol use disorder
United Kingdom
-
Conventional diagnostic tools overlook gaming disorder in female players
United Kingdom
-
More active mitochondria may help chronic myeloid leukemia cells withstand treatment
United Kingdom
-
Low levels of blood pressure protein may flag treatment-resistant psychosis
United Kingdom
-
Lifelong blindness enhances brain processing for better pitch discrimination
United Kingdom
-
Study identifies Piezo channels as targets for orthodontic care
United Kingdom
-
Long non-coding RNAs offer new pathways to overcome cancer treatment resistance
United Kingdom